Xerostomia Therapeutics Market Size & Share, by Product (Artificial Saliva, Salivary Stimulants, Saliva Substitutes, Drugs, Salivary Pens); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 2959
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Xerostomia Therapeutics Market size was valued at USD 2.06 billion in 2023 and is expected to reach USD 3.39 billion by the end of 2036, expanding at around 3.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of xerostomia therapeutics is assessed at USD 2.12 billion.

The increase in adoption of radiation therapy and chemotherapy is likely to lead to an increased incidence of xerostomia, which is estimated to predominantly drive the xerostomia therapeutics market. Other factors driving the market growth include increasing usage of prescription medicines, easy availability and cost-effectiveness of medicines, growing geriatric population base and increasing prevalence of diseases, such as Sjogren’s syndrome, HIV, diabetes, and Alzheimer’s disease, among other diseases.  According to the Centres for Disease Control & Prevention (CDC), every year about 650,000 cancer patients receive chemotherapy in an outpatient oncology clinic.


Xerostomia Therapeutics Market Overview
Get more information on this report: Request Free Sample PDF

Xerostomia Therapeutics Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing adoption of chemotherapy and radiotherapy in cancer treatment
  • Growing prevalence of diseases such as Sjogren’s Syndrome, HIV, diabetes, and Alzheimer’s disease

Challenges

  • Lack of awareness of xerostomia in developing and under-developed economies

Xerostomia Therapeutics Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

3.9%

Base Year Market Size (2023)

USD 2.06 billion

Forecast Year Market Size (2036)

USD 3.39 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Xerostomia Therapeutics Segmentation

The market is segmented based on product into artificial saliva, salivary stimulants, saliva substitutes, drugs, salivary pens and others, out of which, the salivary stimulants segment is anticipated to grab the largest share by the end of 2021 on account of being available in various forms such as mints, sugar-free chewing gums, sprays and mores. A wide range of substitutes for each product is easily available and accessible to patients, thus is expected to drive the growth of the segment.

On the basis of distribution channel, the retail pharmacies and hospital pharmacies segments in the global xerostomia therapeutics market are projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the presence of retail and hospital pharmacies, serving to a larger customer base. Moreover, the online pharmacy segment is estimated to grow at a higher rate during the forecast period due to growing internet penetration in developing countries and changing trends of ordering medicine online.

Our in-depth analysis of the global market includes the following segments

By Product

  • Artificial saliva
  • Salivary stimulants
  • Saliva substitutes
  • Drugs
  • Salivary pens
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Xerostomia Therapeutics Industry - Regional Synopsis

North America Market Statistics

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. North America industry is expected to account for largest revenue share by 2036, due to prominent growth of cases in xerostomia as well as various other diseases associated with dry mouths such as rheumatoid arthritis, HIV, and Sjogren's syndrome. Sjogren Syndrome Foundation frequently carries out awareness camps regarding the therapies and remedies for the people with xerostomia across U.S. and Canada. Furthermore, expanding medical and healthcare infrastructure, ease of availability of treatments, and beneficial compensation scenario are some of the important factors which are helping the market to grow in the North American region.

APAC Market Analysis

Asia Pacific’s market is expected to gain traction and is expected to grow at a faster rate during the forecast period. Increased spending towards healthcare, growing understanding and awareness about chronic diseases are anticipated to strengthen the market in the Asia Pacific.

Research Nester
Xerostomia Therapeutics Market Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Xerostomia Therapeutics Landscape

    • 3M Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Apotex Inc., Church & Dwight Co. Inc.
    • Colgate-Palmolive Co.
    • Cumberland Pharmaceuticals Inc.
    • Daiichi Sankyo Co. Ltd.
    • Eisai Co. Ltd.
    • GlaxoSmithKline Plc
    • Pharmascience Inc.
    • Quest Products Inc.
    • Sun Pharmaceutical Industries Ltd.

Author Credits:  Radhika Pawar


  • Report ID: 2959
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing adoption of chemotherapy and radiotherapy in cancer treatment and growing prevalence of chronic diseases are the key factors driving market growth.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

Lack of awareness of xerostomia in developing and under002Ddeveloped economies is estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about xerostomia and increasing healthcare facilities.

The major players dominating the xerostomia therapeutics market are 3M Company, Colgate-Palmolive Co., Cumberland Pharmaceuticals Inc., GlaxoSmithKline Plc, Sun Pharmaceutical Industries Ltd. among others.
Xerostomia Therapeutics Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample